NIVEIT-ped: Effects of NIV and CPAP on Ventilation Distribution, Measured by EIT, During Deep Sedation in Paediatric Patients

Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (Other)
Overall Status
Recruiting
CT.gov ID
NCT05495477
Collaborator
(none)
20
1
3
42.3
0.5

Study Details

Study Description

Brief Summary

In patients undergoing spontaneous breathing (SB) deep sedation there is a re-distribution of ventilation towards lungs non-dependant areas (ventral areas in supine position).

Non-invasive ventilation (NIV), offering positive pressure, should favour a better ventilation of dependant areas (dorsal areas in supine position), making ventilation more homogeneous and increasing functional residual capacity.

Electrical impedance tomography (EIT) is a non-invasive, non-operator dependent, bedside, radiations-free diagnostic tool, feasible in paediatric patients and repeatable; it allows to study ventilation distribution, and it can measure and calculate also parameters that are related to the homogeneity of ventilation and the response to certain therapeutic maneuvers, such as anaesthesia or PEEP-application.

Uses of EIT in paediatric age are described in literature, but it has never been described as being used in Non-Operating Room Anaesthesia, nor in other cases of SB deep sedation. In addition, the impact of NIV on the distribution of ventilation in healthy paediatric patients undergoing deep sedation has never been described.

Condition or Disease Intervention/Treatment Phase
  • Device: EIT
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Effects of Non-invasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) on Ventilation Distribution, Measured by Electrical Impedance Tomography (EIT), During Deep Sedation in Paediatric Patients
Actual Study Start Date :
Apr 20, 2021
Anticipated Primary Completion Date :
Jun 28, 2023
Anticipated Study Completion Date :
Oct 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Spontaneous breathing

Electrical impedance tomography (EIT).

Device: EIT
Evaluation of ventilation distrinution during deep sedation through EIT

Active Comparator: CPAP mode

Electrical impedance tomography (EIT).

Device: EIT
Evaluation of ventilation distrinution during deep sedation through EIT

Active Comparator: NIV- S/T mode

Electrical impedance tomography (EIT).

Device: EIT
Evaluation of ventilation distrinution during deep sedation through EIT

Outcome Measures

Primary Outcome Measures

  1. Regional Ventilation Delay (pixels %), RDV [1 day]

    It's an index of atelectrauma, supra-distension and in general an inhomogeneous ventilation

Secondary Outcome Measures

  1. Inhomogeneity Index (pixels), GI [1 day]

  2. Gravity Centre(pixels %), GC [1 day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Paediatric age (from 1 to 10 years old)

  • ASA score ≤ 2

  • Sedation time ≥ 30 min

Exclusion Criteria:
  • ASA score ≥ 3

  • Lung pathologies (such as asthma, bronchopulmonary dysplasia, obstructive sleep apnoea) Preterm infant

  • Severe obesity

  • Dorso-lumbar pathologies or other bone pathologies associated with restrictive lung disease (such as scoliosis, kyphosis)

  • Neuromuscular, mitochondrial, metabolic or chromosomal disease with hypotonia

  • CPAP or NIV treatment at home

  • Hand-Bag Ventilation (HBV) during the procedure (loss of the respiratory drive)

  • Non-Total IntraVenous Anaesthesia (TIVA), adherence to the sedation protocol

  • Implantable devices not compatible with EIT (such as pace-makers and implantable cardioverter defibrillator)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico Milano Milan Italy 20122

Sponsors and Collaborators

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Investigators

  • Principal Investigator: Giovanna Chidini, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
ClinicalTrials.gov Identifier:
NCT05495477
Other Study ID Numbers:
  • 2021/2178
First Posted:
Aug 10, 2022
Last Update Posted:
Aug 10, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 10, 2022